Phathom Pharmaceuticals, Inc. announced the FDA approved both Voquezna Triple Pack (vonoprazan tablets, amoxicillin capsules, clarithromycin tablets) and Voquezna Dual Pack (vonoprazan tablets, amoxicillin capsules), for the treatment of Helicobacter pylori (H. pylori) infection in adults.
The Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a change to the terms of the marketing authorisation for the medicinal product Keytruda (pembrolizumab) from Merck Sharp & Dohme for triple negative breast cancer.
GlaxoSmithKline plc and Theravance, Inc. announced the start of a global phase III study, known as IMPACT, to evaluate the...
Basic Therapies Chronic obstructive pulmonary disease (COPD) is set to become the third leading cause of death worldwide.
The National Institute for Health and Care Excellence (NICE) has recommended Forxiga (dapagliflozin) from AstraZeneca as part of a triple...
GlaxoSmithKline has filed its triple combination therapy (umeclidinium bromide+vilanterol+ fluticasone) with the European Medicines Agency as a treatment for patients...
Roche announced the expanded use of the Ventana PD-L1 (SP142) Assay in triple-negative breast cancer (TNBC) for patients living in...
Aim: To evaluate the efficacy and safety of triple therapy with low-dose dapagliflozin plus saxagliptin added to metformin in uncontrolled type 2 diabetes.
Background: Limited data are available for the efficacy of triple therapy with two long-acting bronchodilators and an inhaled corticosteroid in chronic obstructive pulmonary disease (COPD).
Vertex Pharmaceuticals has announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) for the VX...